Want to see BBIO full AI Analyst Report?
BridgeBio Pharma (BBIO) Ownership Overview
3.95% Insiders
26.93% Mutual Funds
0.06% Other Institutional Investors
12.93% ETFs
56.14% Public Companies and
Individual Investors
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail, and individual investors. Approximately 39.91% of the company’s stock is owned by Institutional Investors, 3.95% is owned by Insiders, and 56.14% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 19, 2025 | xxxxxxxxxxxxx | $6319093 | |
Nov 14, 2025 | xxxxxxxxxxxxx | $1683728 | |
Nov 07, 2025 | xxxxxxxxxxxxx | $3888895 | |
Sep 08, 2025 | xxxxxxxxxxxxx | $3933100 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $879419149 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $42267307 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $31213335 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $22353151 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,392,700 | Institution | 7.85% | 1,387,959,759 | |
| 13,725,188 | Institution | 7.00% | 1,237,600,202 | |
| 11,842,434 | Institution | 6.04% | 1,067,832,274 | |
| 9,365,463 | Institution | 4.78% | 844,483,799 | |
| 5,339,458 | Institution | 2.72% | 481,458,928 | |
| 5,089,611 | Institution | 2.60% | 458,930,224 | |
| 5,077,460 | Insider | 2.59% | 457,834,568 | |
| 4,885,076 | Institution | 2.49% | 440,487,303 | |
| 2,728,879 | Institution | 1.39% | 246,063,019 | |
| 2,183,458 | Institution | 1.11% | 196,882,408 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,725,188 | Institution | 7.00% | 1,237,600,202 | |
| 5,339,458 | Institution | 2.72% | 481,458,928 | |
| 2,728,879 | Institution | 1.39% | 246,063,019 | |
| 2,183,458 | Institution | 1.11% | 196,882,408 | |
| 1,716,936 | Institution | 0.88% | 154,816,119 | |
| 1,391,279 | Institution | 0.71% | 125,451,627 | |
| 1,228,256 | Institution | 0.63% | 110,751,844 | |
| 1,009,791 | Institution | 0.52% | 91,052,854 | |
| 982,977 | Institution | 0.50% | 88,635,036 | |
| 944,328 | Institution | 0.48% | 85,150,056 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,559,041 | Institution | 2.84% | 368,342,057 | |
| 4,014,799 | Institution | 2.05% | 266,020,582 | |
| 2,260,101 | Institution | 1.15% | 149,754,292 | |
| 1,918,079 | Institution | 0.98% | 127,091,915 | |
| 1,473,366 | Institution | 0.75% | 115,408,759 | |
| 1,219,363 | Institution | 0.62% | 109,949,962 | |
| 936,666 | Institution | 0.48% | 84,459,173 | |
| 817,003 | Institution | 0.42% | 63,995,845 | |
| 816,010 | Institution | 0.42% | 54,068,823 | |
| 695,964 | Institution | 0.36% | 62,755,074 |
FAQ
Who Owns Bridgebio Pharma (BBIO)?
According to the latest TipRanks data, approximately 0.06% of the company's stock is held by institutional investors, 3.95% is held by insiders, and 56.14% is held by retail investors.
What percentage of Bridgebio Pharma (BBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.06% of Bridgebio Pharma (BBIO) stock is held by institutional investors.
What percentage of Bridgebio Pharma (BBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.14% of Bridgebio Pharma (BBIO) stock is held by retail investors.
Who owns the most shares of Bridgebio Pharma (BBIO)?
Vanguard owns the most shares of Bridgebio Pharma (BBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.